Literature DB >> 9809798

Pituitary adenylate cyclase-activating polypeptide (PACAP) induces duodenal phasic contractions via the vagal cholinergic nerves in sheep.

T Onaga1, Y Harada, K Okamoto.   

Abstract

This study examined the effect of intravenous infusion of pituitary adenylate cyclase-activating polypeptide (PACAP) on duodenal motility in sheep and the mechanism of the action of PACAP. The bilateral cervical vagus nerves were coiled with a cooling device under anesthesia. Duodenal motility was recorded by manometry in conscious animals. PACAP-27, PACAP-38 and vasoactive intestinal polypeptide (VIP) were infused intravenously at 3, 10, 30 and 100 pmol/kg in phase II of the duodenal migrating motor complexes (MMC). PACAP-27 induced a cluster of phasic contractions of the duodenum, while PACAP-38 only augmented the spontaneous contractions. The pattern of PACAP-27-induced contractions was different from that of phase III of MMC, and the contractions were followed by a quiescence period. VIP at only the highest dose induced phase III-like activity of the duodenum. Both the intravenous background infusion of atropine at 10 nmol/kg/min and the reversible cooling blockade of the bilateral cervical vagus nerves blocked the effect of PACAP-27. The application of PACAP-27 at concentrations ranging from 10 nM to 1 microM did not induce contractions of ovine duodenal smooth muscles. These results indicate that PACAP contracts the ovine duodenum via the vagal cholinergic efferent fibers, suggesting that PACAP acts on the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809798     DOI: 10.1016/s0167-0115(98)00046-9

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  7 in total

1.  PACAP modulation of the colon-inferior mesenteric ganglion reflex in the guinea pig.

Authors:  Leonid G Ermilov; Philip F Schmalz; Steven M Miller; Joseph H Szurszewski
Journal:  J Physiol       Date:  2004-07-29       Impact factor: 5.182

2.  Role for pituitary adenylate cyclase activating polypeptide in cystitis-induced plasticity of micturition reflexes.

Authors:  Karen M Braas; Victor May; Peter Zvara; Bernhard Nausch; Jan Kliment; J Dana Dunleavy; Mark T Nelson; Margaret A Vizzard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-12-01       Impact factor: 3.619

3.  PACAP/VIP and receptor characterization in micturition pathways in mice with overexpression of NGF in urothelium.

Authors:  Beatrice M Girard; Susan E Malley; Karen M Braas; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2010-05-07       Impact factor: 3.444

4.  PACAP-mediated ATP release from rat urothelium and regulation of PACAP/VIP and receptor mRNA in micturition pathways after cyclophosphamide (CYP)-induced cystitis.

Authors:  Beatrice M Girard; Amanda Wolf-Johnston; Karen M Braas; Lori A Birder; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2008-06-19       Impact factor: 3.444

5.  Intravesical PAC1 Receptor Antagonist, PACAP(6-38), Reduces Urinary Bladder Frequency and Pelvic Sensitivity in NGF-OE Mice.

Authors:  Beatrice M Girard; Susan E Malley; Morgan M Mathews; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2016-05-04       Impact factor: 3.444

6.  Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons.

Authors:  Marcel Miampamba; Patrizia M Germano; Selin Arli; Helen H Wong; David Scott; Yvette Taché; Joseph R Pisegna
Journal:  Regul Pept       Date:  2002-05-30

7.  Effects of CYP-induced cystitis on PACAP/VIP and receptor expression in micturition pathways and bladder function in mice with overexpression of NGF in urothelium.

Authors:  Beatrice M Girard; John D Tompkins; Rodney L Parsons; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2012-06-15       Impact factor: 2.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.